Clinical trials
Dry Eye Syndromes trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 16 |
| Completed | 13 |
| Recruiting | 5 |
| Terminated | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Taipei Veterans General Hospital, Taiwan | 8 |
| National Taiwan University Hospital | 7 |
| Chang Gung Memorial Hospital | 5 |
| China Medical University Hospital | 4 |
| Chung Shan Medical University | 4 |
| Far Eastern Memorial Hospital | 2 |
| Allergan | 1 |
| Amgen | 1 |
| BRIM Biotechnology Inc. | 1 |
| BioTheraVision, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dry Eye Syndromes | 43 |
| Sjogren's Syndrome | 10 |
| Xerophthalmia | 5 |
| Arthritis, Rheumatoid | 2 |
| Asthenopia | 2 |
| Autoimmune Diseases | 2 |
| Inflammation | 2 |
| Keratoconjunctivitis Sicca | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Alzheimer Disease | 1 |
Trials
Showing 51 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.